NAJAT CHAFIC DAW, M.D.

HOUSTON, TX

Research Active
Pediatrics - Pediatric Hematology-Oncology NPI registered 21+ years 50 publications 1989 – 2025 NPI: 1932102126

Practice Location

1515 HOLCOMBE BLVD
HOUSTON, TX 77030-4000

Phone: (713) 792-6161

What does NAJAT DAW research?

Dr. Daw studies several areas related to mental health and pediatric cancers. She investigates conditions like eating disorders, childhood cancers such as Wilms tumor and osteosarcoma, and their long-term effects on survivors. Her research also delves into how psychological factors influence decision-making, particularly in high-stress scenarios like gambling disorders or threat responses. She focuses on developing better testing methods and treatments for patients to improve their outcomes.

Key findings

  • Her study on the Pavlovian go/no-go task found an increased reliability rate for measuring performance, improving from 0.379 to between 0.696 and 0.989, enhancing its utility in mental health research.
  • In children with relapsed favorable-histology Wilms tumor, the 4-year survival rate was 93.3% for standard-risk relapses, compared to just 58.3% for high-risk and very high-risk relapses.
  • Among 1,257 survivors of childhood osteosarcoma, 13.3% died within 20 years, and they faced chronic health issues at 3.7 times the rate of their siblings, indicating significant long-term health risks.
  • In a clinical trial of TK216 for Ewing Sarcoma, only 2 patients had a complete response, while 1 had a partial response, suggesting limited efficacy but the need for new treatment options.
  • Patients in biomarker-matched therapies for advanced sarcoma showed a higher response rate of 13.1% compared to 4.9% in non-matching trials, and improved median survival rates of 21.5 months versus 12.3 months.

Frequently asked questions

Does Dr. Daw study childhood cancers?
Yes, Dr. Daw's research includes significant studies on childhood cancers such as Wilms tumor and osteosarcoma, focusing on treatment outcomes and long-term effects.
What treatments has Dr. Daw researched?
Dr. Daw has researched a variety of treatment strategies, including new drug trials for Ewing Sarcoma and approaches tailored to advanced sarcoma based on tumor biology.
Is Dr. Daw's work relevant to anxiety disorders?
Yes, her research on decision-making processes in anxiety and stress situations contributes valuable insights into understanding and treating anxiety disorders.
What improvements in mental health testing has Dr. Daw contributed?
Dr. Daw worked on enhancing the reliability of the Pavlovian go/no-go task, which is important for assessing mental health conditions.
How does Dr. Daw's work help childhood cancer survivors?
Her research provides important insights into the long-term health risks faced by childhood cancer survivors, helping healthcare providers manage and improve their care.

Publications in plain English

Outcomes of relapsed favorable-histology Wilms tumor in non-clinical trial setting.

2025

Pediatric blood & cancer

Schneller N, Daw N, Throckmorton W, Mullen E, DeSmith K +5 more

Plain English
This study looked at how well treatments worked for children with relapsed favorable-histology Wilms tumor (FHWT), a type of kidney cancer, when they were treated outside of clinical trials from 2002 to 2018. Among 94 patients, those with standard-risk relapses had a 4-year survival rate of 93.3%, while those with high-risk and very high-risk relapses had a significantly lower survival rate of 58.3%. These findings highlight the need for better treatment options for high-risk patients, as their outcomes were not as good as those in the past. Who this helps: This helps doctors and healthcare providers find better treatments for children with high-risk Wilms tumor relapses.

PubMed

Improving the Reliability of the Pavlovian Go/No-Go Task for Computational Psychiatry Research.

2025

Computational psychiatry (Cambridge, Mass.)

Zorowitz S, Karni G, Paredes N, Daw N, Niv Y

Plain English
This study focused on improving a popular psychological test called the Pavlovian go/no-go task, which helps researchers understand how people respond to rewards and how this relates to mental health. The researchers tested two groups of adults, finding that a new version of the task had a much higher reliability rate for measuring performance—between 0.696 and 0.989, compared to 0.379 in the original version—making it more useful for future studies on individual differences in mental health. This improvement is crucial because it allows researchers to better understand the impact of Pavlovian biases on mental health conditions. Who this helps: This benefits researchers and clinicians in the field of mental health.

PubMed

Comparison of quantitative whole body PET parameters on [Ga]Ga-PSMA-11 PET/CT using ordered Subset Expectation Maximization (OSEM) vs. bayesian penalized likelihood (BPL) reconstruction algorithms in men with metastatic castration-resistant prostate cancer.

2024

Cancer imaging : the official publication of the International Cancer Imaging Society

Ayati N, McIntosh L, Buteau J, Alipour R, Pudis M +3 more

Plain English
This study looked at two different methods for analyzing PET scans in men with a type of advanced prostate cancer. Researchers found that while the new Bayesian penalized likelihood (BPL) method produced slightly higher tumor measurements (like around 17.5% more for the maximum uptake value), both methods showed a strong agreement in results. This matters because it confirms that either method can be used without affecting treatment decisions, but sticking to one method over time is better for tracking changes in a patient's condition. Who this helps: This helps doctors and patients managing metastatic castration-resistant prostate cancer.

PubMed

Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.

2024

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Meyers PA, Federman N, Daw N, Anderson PM, Davis LE +9 more

Plain English
This study looked at a new drug called TK216 for treating Ewing Sarcoma, a rare and aggressive cancer. In a clinical trial with 85 patients, TK216 was given as a 14-day infusion along with the standard drug vincristine, and while it was generally well tolerated, only a few patients experienced significant improvement—two had a complete response, one had a partial response, and 14 maintained stable disease over six months. This is important because Ewing Sarcoma has a poor prognosis, and finding new treatment options for patients who have already tried multiple therapies is critical. Who this helps: This helps patients with relapsed Ewing Sarcoma and their doctors seeking new treatment options.

PubMed

Long-term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS).

2024

Pediatric blood & cancer

Becktell K, Chen Y, Yasui Y, Phelan R, Armstrong GT +8 more

Plain English
This study looked at the long-term effects on people who survived osteosarcoma, a type of bone cancer, after being treated between 1970 and 1999. Among 1,257 survivors followed for an average of 24.4 years, 13.3% died from any cause within 20 years, and they were 3.7 times more likely to face chronic health issues compared to their siblings. This research highlights that while treatment has improved survival rates, it can lead to serious long-term health problems, especially for those who received certain types of chemotherapy or limb-salvage surgeries. Who this helps: This helps childhood cancer survivors and their healthcare providers understand the long-term risks they face.

PubMed

Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).

2023

Clinical cancer research : an official journal of the American Association for Cancer Research

Carmagnani Pestana R, Moyers JT, Roszik J, Sen S, Hong DS +29 more

Plain English
This study looked at how patients with advanced sarcoma fared when they participated in early-phase clinical trials that matched their tumor's specific characteristics with targeted therapies. Researchers found that those enrolled in matching trials had a significantly higher response rate of 13.1% compared to 4.9% in non-matching trials, better survival rates (median of 21.5 months vs. 12.3 months), and longer time without disease progression (5.5 months vs. 2.4 months). This matters because it shows that personalizing treatment based on tumor biology can lead to better outcomes for patients who have already exhausted standard treatment options. Who this helps: This helps patients with advanced sarcoma and their doctors in making treatment decisions.

PubMed

Restrictive eating across a spectrum from healthy to unhealthy: behavioral and neural mechanisms.

2022

Psychological medicine

Foerde K, Schebendach JE, Davis L, Daw N, Walsh BT +2 more

Plain English
This study looked at how food choices and brain activity differ between women with anorexia nervosa (AN) and those without eating disorders. Researchers found that while healthy women (whether dieting or not) opted for more high-fat foods, both groups with AN focused more on healthiness rather than taste, leading to lower caloric intake. Specifically, the brain activity of those with AN was linked to choosing fewer high-fat foods, highlighting different mental and neural processes involved in eating restrictions. Who this helps: This research benefits patients with eating disorders and healthcare providers working to treat them.

PubMed

Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2.

2021

Frontiers in oncology

Ragoonanan D, Khazal SJ, Mejia R, Ewing L, Durand JB +24 more

Plain English
This study focused on young cancer patients who are treated with new immunotherapies and might develop severe side effects that look similar to COVID-19 symptoms. The researchers presented two cases that were difficult to diagnose because the patients experienced symptoms from both COVID-19 and a related condition called Multi-Inflammatory Syndrome-Adult (MIS-A) after their cancer treatment. These findings highlight the need for careful monitoring of symptoms in young patients to quickly identify and address any complications from their treatment or infections. Who this helps: This helps pediatric and young adult cancer patients and their doctors.

PubMed

Changes in brain and behavior during food-based decision-making following treatment of anorexia nervosa.

2021

Journal of eating disorders

Foerde K, Walsh BT, Dalack M, Daw N, Shohamy D +1 more

Plain English
This study looked at how brain activity and eating behavior changed in women with anorexia nervosa after they received treatment. Researchers found that while the patients continued to choose similar amounts of high-fat foods over time, reduced brain activity in a specific area (the caudate) after treatment was linked to a greater selection of these foods. This matters because it highlights a connection between brain function and eating choices in anorexia, indicating that successful treatment should address both food behaviors and the underlying brain mechanisms. Who this helps: This helps patients with anorexia nervosa and their healthcare providers.

PubMed

Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric Sarcomas.

2021

Frontiers in oncology

Dao L, Ragoonanan D, Batth I, Satelli A, Foglesong J +13 more

Plain English
Researchers studied a type of blood marker, called cell-surface vimentin-positive circulating tumor cells (CSV+ CTCs), in 92 young patients with sarcoma, a type of cancer. They discovered that 85.3% of the patients with CSV+ CTCs had a worse chance of surviving compared to those without this marker. This is important because it offers a new way to assess disease status in sarcoma patients, which may reduce the need for frequent scans that can cause anxiety and increase cancer risk. Who this helps: This benefits young cancer patients and their doctors by offering a better way to monitor disease progression.

PubMed

Slow escape decisions are swayed by trait anxiety.

2019

Nature human behaviour

Fung BJ, Qi S, Hassabis D, Daw N, Mobbs D

Plain English
Researchers studied how anxiety affects people's decisions to escape from threats that come at different speeds. They found that individuals with higher anxiety levels tend to escape earlier when facing slow-moving threats, and this behavior is linked to increased brain activity in areas involved in cognitive decision-making, such as the ventral hippocampus and medial prefrontal cortex. This finding is important because it shows that anxiety influences how people think and act in risky situations, especially in planning strategic escapes. Who this helps: This benefits patients with anxiety disorders, as it provides insight into their behavior during threatening situations.

PubMed

Reduced model-based decision-making in gambling disorder.

2019

Scientific reports

Wyckmans F, Otto AR, Sebold M, Daw N, Bechara A +5 more

Plain English
This study examined how people with gambling disorder make decisions compared to healthy individuals. Researchers found that those with gambling problems struggled with flexible, goal-oriented decision-making, especially after losing money, showing a slower reaction to making decisions when outcomes weren't rewarding. This is important because it helps us understand the decision-making issues linked to gambling addiction, which can inform better treatment approaches. Who this helps: This benefits patients with gambling disorders and the doctors treating them.

PubMed

Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor.

2018

The oncologist

Menegaz BA, Cuglievan B, Benson J, Camacho P, Lamhamedi-Cherradi SE +9 more

Plain English
This study looked at how well the medication pazopanib works for patients with desmoplastic small round cell tumor (DSRCT), a rare and aggressive cancer. Out of 29 patients treated after other therapies had failed, 55% had stable disease and the average time without the disease getting worse was about 5.6 months. Additionally, patients lived for an average of 15.7 months after starting pazopanib. This research is important because it shows that pazopanib can be an effective treatment option for patients with DSRCT, who currently have few alternatives. Who this helps: This helps patients with desmoplastic small round cell tumor and their healthcare providers.

PubMed

How cognitive and reactive fear circuits optimize escape decisions in humans.

2018

Proceedings of the National Academy of Sciences of the United States of America

Qi S, Hassabis D, Sun J, Guo F, Daw N +1 more

Plain English
Researchers studied how humans decide when to flee from a threat, focusing on two different types of fear responses: quick reactions to immediate danger and more thoughtful choices when the threat is farther away. They found that quick escapes use certain brain areas, while more deliberated decisions engage different brain regions linked to complex thinking. This is important because understanding these processes can help in figuring out how humans optimize their responses to threats, which is crucial for survival in risky situations. Who this helps: This helps patients dealing with anxiety or trauma by offering insights into their reactions to stress.

PubMed

Analysis of HSP27 and the Autophagy Marker LC3BPuncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients.

2018

Molecular cancer therapeutics

Livingston JA, Wang WL, Tsai JW, Lazar AJ, Leung CH +7 more

Plain English
This study looked at how certain proteins, specifically HSP27 and LC3B, can predict outcomes for patients with osteosarcoma (a type of bone cancer) who underwent chemotherapy. Researchers examined 394 tumor samples from 260 patients and found that high levels of HSP27 and the presence of LC3B puncta were linked to worse survival rates. Specifically, 10-year survival rates were 75% for patients with certain favorable markers and only 25% for those with unfavorable markers. Who this helps: This information benefits doctors and oncologists by helping them identify high-risk osteosarcoma patients and tailor their treatment plans accordingly.

PubMed

Cortical correlates of amblyopia.

2018

Visual neuroscience

Kiorpes L, Daw N

Plain English
This research paper examines the different vision problems associated with amblyopia, a condition often referred to as "lazy eye." It found that traditional treatments, like patching, may improve some aspects of visual sharpness but still leave other vision issues unresolved. Specifically, the study highlights that brain areas responsible for processing visual information show changes that don't fully explain why patients continue to experience problems with depth perception and motion, pointing to the need for future research on how the brain manages visual information in amblyopia. Who this helps: This research benefits patients with amblyopia and their eye care providers by providing insights into potential areas for improved treatment.

PubMed

Computational approaches to fMRI analysis.

2017

Nature neuroscience

Cohen JD, Daw N, Engelhardt B, Hasson U, Li K +6 more

Plain English
This study looked at how new computer methods can improve the analysis of brain scans from fMRI. Researchers found that using advanced techniques like machine learning and statistical models allows for better understanding of brain activity during tasks, compared to older methods. This is important because it helps scientists gain deeper insights into complex human thoughts and memories, potentially leading to breakthroughs in how we understand the brain. Who this helps: Patients and researchers studying brain function.

PubMed

Fronto-striatal organization: Defining functional and microstructural substrates of behavioural flexibility.

2016

Cortex; a journal devoted to the study of the nervous system and behavior

Morris LS, Kundu P, Dowell N, Mechelmans DJ, Favre P +6 more

Plain English
This research studied how different parts of the brain work together to help us adapt our behaviors. The scientists discovered that three groups of brain areas — those linked to emotions, movement, and thinking — each play unique roles in behavior. For instance, when people used goal-directed actions, connections in the medial orbitofrontal cortex were more active, while habits were connected to complex structures in another area called the putamen. Why it matters: Understanding these connections can improve treatments for disorders that impact decision-making and behavior, like addiction or ADHD. Who this helps: This helps patients with behavioral disorders and their doctors.

PubMed

Rethinking Extinction.

2015

Neuron

Dunsmoor JE, Niv Y, Daw N, Phelps EA

Plain English
This study looks at how we stop certain learned behaviors when the expected rewards no longer happen. The researchers found that relying solely on traditional methods of "extinction"—which means forgetting or unlearning behaviors—isn't enough to fully prevent unwanted habits returning. They propose new strategies that build on the latest scientific knowledge to better change these behaviors, which is important because it can help people overcome issues like addiction or anxiety. Who this helps: This benefits patients struggling with harmful behaviors, such as those dealing with addiction or anxiety disorders.

PubMed

Motivation and value influences in the relative balance of goal-directed and habitual behaviours in obsessive-compulsive disorder.

2015

Translational psychiatry

Voon V, Baek K, Enander J, Worbe Y, Morris LS +4 more

Plain English
This study examined how people with obsessive-compulsive disorder (OCD) make decisions compared to healthy individuals, focusing on their motivation and responses to rewards and losses. Researchers found that people with OCD were less likely to make choices based on goals when rewards were involved, but they did shift to more goal-directed behavior when faced with losses. They also showed stronger patterns of habitual behavior regardless of the type of outcome, meaning they repeated certain actions more often, especially when their compulsions were stronger. Who this helps: This research helps patients with OCD and their doctors by providing insights into decision-making patterns that could guide treatment strategies.

PubMed

Representation of aversive prediction errors in the human periaqueductal gray.

2014

Nature neuroscience

Roy M, Shohamy D, Daw N, Jepma M, Wimmer GE +1 more

Plain English
This study looked at how people learn to avoid pain and how their brains respond to unexpected pain. Researchers found that a part of the brain called the periaqueductal gray (PAG) represents signals about when pain is greater or less than expected. Specifically, they discovered that the PAG works with other brain areas to process these signals, which helps determine how we behave in response to pain. Who this helps: This information can benefit patients by improving pain management strategies.

PubMed

Jaw dysfunction related to pterygoid and masseter muscle dosimetry after radiation therapy in children and young adults with head-and-neck sarcomas.

2012

International journal of radiation oncology, biology, physics

Krasin MJ, Wiese KM, Spunt SL, Hua CH, Daw N +9 more

Plain English
This study looked at how radiation therapy affects jaw function in children and young adults being treated for head and neck tumors. Researchers found that issues with jaw movement were linked to factors like the extent of surgery and the amount of radiation received by specific jaw muscles, with doses above 40 Gy leading to more significant loss of jaw function. Understanding these effects can help doctors better manage treatment to reduce the risk of jaw problems in young patients. Who this helps: This helps patients undergoing radiation therapy for head and neck tumors, as well as their healthcare providers.

PubMed

Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum.

2011

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Debelenko LV, Raimondi SC, Daw N, Shivakumar BR, Huang D +2 more

Plain English
Researchers studied six cases of kidney cancer in children and found that two of these cancers had an unusual genetic change involving the ALK gene. One of these cases contained a new gene fusion between ALK and a gene called VCL, which could play a role in how the cancer develops. This discovery suggests that kidney cancer may be connected to ALK in a similar way to some other cancers, and it highlights the need for better genetic testing to help patients receive targeted therapies that could improve their treatment options. Who this helps: This helps pediatric cancer patients and their doctors.

PubMed

States versus rewards: dissociable neural prediction error signals underlying model-based and model-free reinforcement learning.

2010

Neuron

Gläscher J, Daw N, Dayan P, O'Doherty JP

Plain English
This study looked at how our brains learn from experiences, focusing on two types of learning: one that relies directly on outcomes (model-free) and another that builds a mental map of situations and their results (model-based). Researchers found specific brain activity patterns linked to these learning types: the intraparietal sulcus and lateral prefrontal cortex showed signals for the indirect learning, while the ventral striatum related to direct outcomes. These insights matter because they reveal how different learning processes function in our brains, which can influence understanding behaviors and decision-making. Who this helps: This benefits researchers and clinicians studying learning and decision-making in patients with conditions affecting these processes.

PubMed

Tonic dopamine modulates exploitation of reward learning.

2010

Frontiers in behavioral neuroscience

Beeler JA, Daw N, Frazier CR, Zhuang X

Plain English
This study looked at how dopamine affects how animals learn and make choices about rewards in a more natural setting. Researchers found that mice with high levels of dopamine worked harder to get food, pressing expensive levers more often than regular mice, but both types of mice responded quickly to changes in food costs. This shows that while high dopamine levels do not slow down learning, they limit how much past experiences influence current decisions, which can affect how motivated they are to act. Who this helps: This helps researchers and doctors better understand reward-related behaviors in conditions like addiction or neuropsychological disorders.

PubMed

Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients.

2009

Brain : a journal of neurology

Bódi N, Kéri S, Nagy H, Moustafa A, Myers CE +5 more

Plain English
This study looked at how young patients with Parkinson's disease respond to rewards and punishments before and after taking certain medications that boost dopamine, which is a brain chemical linked to motivation and pleasure. Researchers found that patients who had never taken these medications struggled with reward processing and seeking new experiences, but after 12 weeks of treatment with dopamine medications, their reward responses improved, and they became more eager for new experiences, although their punishment processing worsened. This research is important because it highlights how these medications can change not only how patients experience pleasure but also how they respond to potential negative outcomes. Who this helps: This helps young patients with Parkinson's disease and their doctors understand the effects of dopamine medications on behavior and decision-making.

PubMed

Sperm cryopreservation practices among adolescent cancer patients at risk for infertility.

2009

Pediatric hematology and oncology

Klosky JL, Randolph ME, Navid F, Gamble HL, Spunt SL +4 more

Plain English
This study focused on young males, ages 13 and older, diagnosed with cancer and looked at whether they were preserving their sperm to avoid infertility later. It found that only 28.1% of young patients at risk for infertility actually banked their sperm. The study also revealed that those more likely to bank sperm typically had certain types of cancer, came from higher-income backgrounds, and were not from Evangelical religious groups. This is important because many young cancer patients may not be aware of or take advantage of fertility preservation options, so improving access and education is crucial. Who this helps: This helps adolescent cancer patients by providing them with more information and support for preserving their fertility.

PubMed

Effects of age-dependent membrane transport changes on the homeostasis of senescent human red blood cells.

2007

Blood

Lew VL, Daw N, Etzion Z, Tiffert T, Muoma A +2 more

Plain English
This study looked at how red blood cells (RBCs) change as they age, specifically focusing on how well they transport calcium across their membranes. The researchers found that older RBCs have lower activity of a key pump that helps manage calcium levels, which correlates with higher levels of a marker for aging, called Hb A1c. This is important because understanding how RBCs change over time can help improve treatment strategies for age-related blood disorders. Who this helps: Patients with age-related blood conditions and their doctors.

PubMed

Age decline in the activity of the Ca2+-sensitive K+ channel of human red blood cells.

2007

The Journal of general physiology

Tiffert T, Daw N, Etzion Z, Bookchin RM, Lew VL

Plain English
This study looked at how the activity of a specific channel in human red blood cells (the Gardos channel) changes as the cells age. Researchers found that younger red blood cells had a higher ability to let potassium ions through the Gardos channel, while older cells showed a steady decline in this activity. Specifically, the maximum potassium flow was highest in young red blood cells and decreased as the cells aged, showing that the dehydration process in red blood cells is affected by their age. Who this helps: This finding can benefit patients with sickle cell disease and other conditions related to red blood cell health.

PubMed

Differential encoding of losses and gains in the human striatum.

2007

The Journal of neuroscience : the official journal of the Society for Neuroscience

Seymour B, Daw N, Dayan P, Singer T, Dolan R

Plain English
This study looked at how the human brain, specifically the striatum, processes financial gains and losses during decision-making. Researchers found that different areas of the striatum are activated when people think about rewards versus losses, with the front part responding more to gains and the back part more to losses. This is important because it helps us understand how our brains react to financial risks and rewards, which can influence decisions in our everyday lives. Who this helps: This helps patients, particularly those making financial decisions or coping with economic stress.

PubMed

Distribution of dehydration rates generated by maximal Gardos-channel activation in normal and sickle red blood cells.

2005

Blood

Lew VL, Tiffert T, Etzion Z, Perdomo D, Daw N +2 more

Plain English
The study looked at how healthy and sickle red blood cells (RBCs) dehydrate when exposed to calcium, which is important for understanding sickle cell disease. The researchers found that both normal and sickle RBCs showed similar rates of dehydration when calcium levels were high, contrary to earlier beliefs that some cells might be much more susceptible. This uniformity in dehydration rates suggests that the way RBCs respond to calcium, rather than varying amounts of channels, is key in determining which cells dehydrate during sickling episodes. Who this helps: This benefits patients with sickle cell disease by providing insights for better treatments.

PubMed

The incidence and prognosis of osteosarcoma skip metastases.

2004

Clinical orthopaedics and related research

Sajadi KR, Heck RK, Neel MD, Rao BN, Daw N +5 more

Plain English
This study looked at how often and how serious "skip metastases" (cancer spread to nearby areas that are not directly connected) occur in young patients with a type of bone cancer called osteosarcoma. Out of 155 patients studied, 10 (6.5%) had skip metastases, and all of them died, with an average survival time of 32.5 months after diagnosis. This matters because it highlights that even with modern treatment methods, patients with skip metastases face a very poor outlook, so doctors need to provide clear information about potential outcomes. Who this helps: This helps doctors and patients by informing treatment plans and expectations.

PubMed

Use of a smooth press-fit stem preserves physeal growth after tumor resection.

2004

Clinical orthopaedics and related research

Neel MD, Heck R, Britton L, Daw N, Rao BN

Plain English
This study looked at how a special type of implant used in children with bone tumors affects their bone growth. After surgery to remove the tumor, the implant was placed in six kids, and researchers found that the bones near the implant grew normally, with an average growth of about 2.4 cm in the treated limb, similar to the 2.3 cm growth seen in the untreated limb. This is important because it shows that this innovative implant doesn't hinder growth in children after tumor removal. Who this helps: Patients with osteosarcoma and their doctors.

PubMed

Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice.

2004

Cancer research

Stewart CF, Leggas M, Schuetz JD, Panetta JC, Cheshire PJ +7 more

Plain English
This study looked at how gefitinib, a cancer drug, works when combined with another drug called irinotecan in mice with tumors. The researchers found that when used together, these drugs were more effective than if they were used separately—showing better results in four out of eight tumor types tested. This is important because it suggests that gefitinib can help increase the effectiveness of irinotecan, especially in tumors that are resistant to the drug. Who this helps: This benefits cancer patients, particularly those with tumors that resist standard treatments.

PubMed

LTP and LTD vary with layer in rodent visual cortex.

2004

Vision research

Daw N, Rao Y, Wang XF, Fischer Q, Yang Y

Plain English
This research focused on how different layers of the visual cortex in mice affect two key processes: long-term potentiation (LTP) and long-term depression (LTD), which are important for how the brain adapts and learns. The study found that when both LTP and LTD were completely blocked, another process called ocular dominance plasticity (ODP) also stopped, indicating a strong connection. This finding is significant because it shows that LTP and LTD work differently depending on the layer of the visual cortex, which helps us understand brain function and could inform treatments for vision-related issues. Who this helps: This helps researchers and doctors working on visual disorders.

PubMed

Painful limp in a 10-year-old boy.

2003

Clinical orthopaedics and related research

Neel MD, Toy PC, Kaste SC, Jenkins JJ, Daw N +1 more

PubMed

Roles of protein kinase A and protein kinase G in synaptic plasticity in the visual cortex.

2003

Cerebral cortex (New York, N.Y. : 1991)

Liu S, Rao Y, Daw N

Plain English
This study examined how two proteins, PKA and PKG, affect the brain's ability to change and adapt in the visual cortex, particularly regarding visual processing. The researchers found that blocking PKA drastically weakened both long-term potentiation (LTP) and long-term depression (LTD), while inhibiting PKG only impacted LTP. These findings highlight that PKA is essential for how the brain adjusts to changes in visual input, suggesting that LTD is just as important as LTP for these adjustments. Who this helps: This helps patients with visual disorders and neurologists studying brain plasticity.

PubMed

Distribution of plasma membrane Ca2+ pump activity in normal human red blood cells.

2003

Blood

Lew VL, Daw N, Perdomo D, Etzion Z, Bookchin RM +1 more

Plain English
This study looked at how well a specific calcium pump works in red blood cells from healthy people. Researchers found that these cells show a wide range of activity levels, with many having higher calcium pumping abilities than average. Understanding this variation is important because it could explain how certain blood cells behave in health and disease situations. Who this helps: This helps doctors understand red blood cell behavior in different patients.

PubMed

Local analysis of behaviour in the adjusting-delay task for assessing choice of delayed reinforcement.

2002

Neural networks : the official journal of the International Neural Network Society

Cardinal RN, Daw N, Robbins TW, Everitt BJ

Plain English
This study looked at how rats make choices between receiving rewards after different delays, specifically comparing a fixed delay to a variable one. The researchers found that the rats didn't show a clear preference based on the changing delays, suggesting that their choices might not be influenced by the timing of rewards as previously thought. This matters because it could change how researchers understand decision-making and delay sensitivity in both animals and humans. Who this helps: This helps researchers studying behavior and decision-making in both humans and animals.

PubMed

A fast and simple screening test to search for specific inhibitors of the plasma membrane calcium pump.

2001

The Journal of laboratory and clinical medicine

Tiffert T, Daw N, Perdomo D, Lew VL

Plain English
This study developed a quick and simple test to find specific blockers of the plasma membrane calcium pump, which helps regulate calcium levels in cells. The researchers designed a method using human red blood cells, showing that when the pump is blocked, the cells retain calcium and remain intact, while normal cells break apart. This method can effectively screen many potential drugs at once, promising advances in understanding cell function and developing new treatments. Who this helps: This benefits researchers and pharmaceutical companies looking for new therapies related to calcium regulation in cells.

PubMed

Controlled production of active cathepsin D in retinal pigment epithelial cells following adenovirus-mediated gene delivery.

2000

Molecular therapy : the journal of the American Society of Gene Therapy

Lai CM, Robertson T, Papadimitriou J, Shen WY, Daw N +2 more

Plain English
This study looked at how a modified virus can deliver a gene to retinal pigment epithelial cells to produce a protein called cathepsin D, which is important for cell function. The researchers found that while the cells produced more of the inactive form of this protein (procathepsin D), the actual activity of cathepsin D did not exceed normal levels, meaning the cells remained stable without unwanted changes. This is important because it shows that the production of cathepsin D can be safely increased without causing damage to the eye tissues. Who this helps: This benefits patients with retinal diseases that could be treated through gene therapy.

PubMed

Distribution of cathepsin D in human eyes with or without age-related maculopathy.

1999

Experimental eye research

Rakoczy PE, Sarks SH, Daw N, Constable IJ

Plain English
This study looked at cathepsin D, an enzyme important for breaking down proteins in the eyes, particularly in the context of age-related maculopathy (a common eye condition that can lead to vision loss). The researchers found that cathepsin D was present in all eye samples they examined, with a slight increase around certain lesions known as hyalinized drusen, but the enzyme's levels did not decrease with age or the severity of age-related maculopathy. This matters because understanding cathepsin D's role could lead to better insights into how age-related maculopathy develops and possibly influence future treatments. Who this helps: Patients at risk of or affected by age-related maculopathy.

PubMed

Recombinant adenovirus-mediated gene delivery into the rat retinal pigment epithelium in vivo.

1998

Australian and New Zealand journal of ophthalmology

Rakoczy PE, Lai CM, Shen WY, Daw N, Constable IJ

Plain English
This study looked at using a special virus to deliver a gene into the cells of the retina in rats. They found that after injecting the virus, the target cells showed low levels of the delivered gene at first, but by seven days, it was highly active and continued to work well for two weeks. This is important because it shows a promising way to deliver genes specifically to retinal cells, which could help treat eye diseases. Who this helps: Patients with retinal diseases.

PubMed

The effect of visual experience on development of NMDA receptor synaptic transmission in kitten visual cortex.

1992

The Journal of neuroscience : the official journal of the Society for Neuroscience

Fox K, Daw N, Sato H, Czepita D

Plain English
This study looked at how keeping kittens in the dark affects their brain development, specifically how their visual systems work. Researchers found that if kittens were raised in darkness for six weeks, their brain cells didn't show the usual decrease in a certain type of signal (the NMDA component) that happens with visual experience. When they were exposed to light for just ten days afterward, their visual responses adjusted but didn’t fully return to normal levels seen in kittens raised in light, indicating that visual experiences shape brain development more than just age alone. Who this helps: This research benefits scientists studying brain development and could inform therapies for conditions related to visual processing.

PubMed

Dark-rearing delays the loss of NMDA-receptor function in kitten visual cortex.

1991

Nature

Fox K, Daw N, Sato H, Czepita D

Plain English
This study looked at how keeping kittens in the dark affects a specific type of brain receptor important for vision. Researchers found that kittens raised in darkness showed a delay in the decline of NMDA receptor function in their visual cortex, meaning the receptors stayed active longer during a critical time for visual development. This matters because it suggests that NMDA receptors are key for helping the brain properly organize visual information during early life. Who this helps: This helps researchers and clinicians working with young animals and potentially impacts approaches to visual development in humans.

PubMed

The effect of age on binding of MK-801 in the cat visual cortex.

1991

Brain research. Developmental brain research

Gordon B, Daw N, Parkinson D

Plain English
This study looked at how age affects the binding of a substance called MK-801 in the visual cortex of cats. Researchers found that MK-801 binds most strongly around 6 weeks of age, decreases slightly by 83 days, and then drops significantly in adult cats. This research is important because it shows how the brain's ability to adapt changes as cats grow older, which could have implications for understanding visual development in mammals. Who this helps: This helps researchers and veterinarians studying brain development and visual processing in cats and other animals.

PubMed

GAP-43 in the cat visual cortex during postnatal development.

1990

Visual neuroscience

McIntosh H, Daw N, Parkinson D

Plain English
Researchers studied the levels of a protein called GAP-43 in the visual cortex of cats as they grow, to understand how it relates to the brain's ability to adapt and change during a specific development window. They found that GAP-43 levels were high in young cats (7-10 ng per microgram of protein at 5 days old) but dropped significantly by 60 days old (60-80% lower), continuing to decline until reaching adult levels of 0.5-2 ng. This information is important because it helps explain how the brain becomes less adaptable after early development, which could influence therapies for visual and developmental disorders. Who this helps: This helps doctors and researchers working with children and individuals with visual development issues.

PubMed

The effect of varying stimulus intensity on NMDA-receptor activity in cat visual cortex.

1990

Journal of neurophysiology

Fox K, Sato H, Daw N

Plain English
The study examined how different intensities of visual stimuli affect specific receptors in the cat's brain, particularly focusing on NMDA receptors, which play a role in processing visual information. Researchers found that small changes in visual contrast could significantly alter the neurons' activity, with NMDA receptor activity influencing responses at a continuous level rather than just at a specific threshold. Specifically, applying a blocker reduced the responsiveness of certain brain cell layers by about 59%. Who this helps: This research benefits neuroscientists and other researchers interested in understanding visual processing and related disorders.

PubMed

A GAP-43-like protein in cat visual cortex.

1989

Visual neuroscience

McIntosh H, Parkinson D, Meiri K, Daw N, Willard M

Plain English
Researchers studied a specific protein in the visual part of a kitten's brain and found it behaves like another well-known protein called GAP-43, which helps with brain development. They discovered that the concentration of this cat GAP-43 protein was higher in younger kittens and decreased as they got older, with some measurements indicating significant drops in protein levels. Understanding this protein's changes is important because it can help scientists learn more about brain development and recovery after injury. Who this helps: This helps researchers and doctors working with young patients or those recovering from brain injuries.

PubMed

The location and function of NMDA receptors in cat and kitten visual cortex.

1989

The Journal of neuroscience : the official journal of the Society for Neuroscience

Fox K, Sato H, Daw N

Plain English
This research looked at how NMDA receptors in the visual cortex of cats and kittens respond at different ages. The study found that using a specific drug reduced visual responses by about one-third in younger cats and affected older ones differently; it mainly reduced spontaneous activity. Understanding how NMDA receptors work is important because it may reveal how young animals develop their vision and how these processes change as they grow up. Who this helps: This benefits researchers studying visual development in animals and potentially in humans.

PubMed

Frequent Co-Authors

Teresa Tiffert Zipora Etzion Robert M Bookchin Virgilio L Lew K Fox H Sato Yael Niv Joseph A Ludwig Jonathan B Gill Daphna Shohamy

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.